What do systematic reviews say?

Erlotinib vs control

Erlotinib showed no clear difference in overall survival compared with control (high certainty).

• First‐line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non‐squamous non‐small cell… 2021 · Cochrane Headline outcomes only
  HR 0.95 [0.75, 1.22]
  3 studies · 429 participants
  High